Cargando…
Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer
Background: The purpose of this study was to evaluate the clinical outcomes following postoperative chemotherapy (XP) versus chemoradiotherapy (XP-RT) according to mesenchymal subtype based on RNA sequencing in gastric cancer (GC) in a cohort of the Adjuvant chemoRadioTherapy In Stomach Tumor (ARTIS...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226608/ https://www.ncbi.nlm.nih.gov/pubmed/32290335 http://dx.doi.org/10.3390/cancers12040943 |
_version_ | 1783534328665341952 |
---|---|
author | Yu, Jeong Il Park, Hee Chul Lee, Jeeyun Choi, Changhoon Kang, Won Ki Park, Se Hoon Kim, Seung Tae Sohn, Tae Sung Lee, Jun Ho An, Ji Yeong Choi, Min Gew Bae, Jae Moon Kim, Kyoung-Mee Han, Heewon Kim, Kyunga Kim, Sung Lim, Do Hoon |
author_facet | Yu, Jeong Il Park, Hee Chul Lee, Jeeyun Choi, Changhoon Kang, Won Ki Park, Se Hoon Kim, Seung Tae Sohn, Tae Sung Lee, Jun Ho An, Ji Yeong Choi, Min Gew Bae, Jae Moon Kim, Kyoung-Mee Han, Heewon Kim, Kyunga Kim, Sung Lim, Do Hoon |
author_sort | Yu, Jeong Il |
collection | PubMed |
description | Background: The purpose of this study was to evaluate the clinical outcomes following postoperative chemotherapy (XP) versus chemoradiotherapy (XP-RT) according to mesenchymal subtype based on RNA sequencing in gastric cancer (GC) in a cohort of the Adjuvant chemoRadioTherapy In Stomach Tumor (ARTIST) trial. Methods: Of the 458 patients enrolled in the ARTIST trial, formalin-fixed, paraffin-embedded (FFPE) specimens were available from 106 (23.1%) patients for RNA analysis. The mesenchymal subtype was classified according to a previously reported 71-gene MSS/EMT signature using the NanoString assay. Results: Of the 106 patients analyzed (50 in XP arm, 56 in XP-RT arm), 36 (34.0%) patients were categorized as mesenchymal subtype by NanoString assay. Recurrence-free survival (RFS, p = 0.009, hazard ratio (HR) = 2.11, 95% confidence interval (CI): 1.21–3.70) and overall survival (OS, p = 0.003, HR = 2.28, 95% CI: 1.31–3.96) were significantly lower in the mesenchymal subtype than in the non-mesenchymal subtype. In terms of post-operative radiotherapy (RT), mesenchymal subtype was not an independent variable to predict RFS or OS regardless to the assigned arm (XP with or without RT) in this patient cohort. However, there was a trend in the adjuvant XP arm, which showed higher OS than the XP-RT arm for the mesenchymal subtype and lower OS than the XP-RT arm for the non-mesenchymal subtype. Conclusions: We could not determine any significant differences between the mesenchymal and non-mesenchymal subtypes with respect to the effects of adjuvant XP with or without RT in gastric cancer following curative surgery. |
format | Online Article Text |
id | pubmed-7226608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72266082020-05-18 Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer Yu, Jeong Il Park, Hee Chul Lee, Jeeyun Choi, Changhoon Kang, Won Ki Park, Se Hoon Kim, Seung Tae Sohn, Tae Sung Lee, Jun Ho An, Ji Yeong Choi, Min Gew Bae, Jae Moon Kim, Kyoung-Mee Han, Heewon Kim, Kyunga Kim, Sung Lim, Do Hoon Cancers (Basel) Article Background: The purpose of this study was to evaluate the clinical outcomes following postoperative chemotherapy (XP) versus chemoradiotherapy (XP-RT) according to mesenchymal subtype based on RNA sequencing in gastric cancer (GC) in a cohort of the Adjuvant chemoRadioTherapy In Stomach Tumor (ARTIST) trial. Methods: Of the 458 patients enrolled in the ARTIST trial, formalin-fixed, paraffin-embedded (FFPE) specimens were available from 106 (23.1%) patients for RNA analysis. The mesenchymal subtype was classified according to a previously reported 71-gene MSS/EMT signature using the NanoString assay. Results: Of the 106 patients analyzed (50 in XP arm, 56 in XP-RT arm), 36 (34.0%) patients were categorized as mesenchymal subtype by NanoString assay. Recurrence-free survival (RFS, p = 0.009, hazard ratio (HR) = 2.11, 95% confidence interval (CI): 1.21–3.70) and overall survival (OS, p = 0.003, HR = 2.28, 95% CI: 1.31–3.96) were significantly lower in the mesenchymal subtype than in the non-mesenchymal subtype. In terms of post-operative radiotherapy (RT), mesenchymal subtype was not an independent variable to predict RFS or OS regardless to the assigned arm (XP with or without RT) in this patient cohort. However, there was a trend in the adjuvant XP arm, which showed higher OS than the XP-RT arm for the mesenchymal subtype and lower OS than the XP-RT arm for the non-mesenchymal subtype. Conclusions: We could not determine any significant differences between the mesenchymal and non-mesenchymal subtypes with respect to the effects of adjuvant XP with or without RT in gastric cancer following curative surgery. MDPI 2020-04-10 /pmc/articles/PMC7226608/ /pubmed/32290335 http://dx.doi.org/10.3390/cancers12040943 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yu, Jeong Il Park, Hee Chul Lee, Jeeyun Choi, Changhoon Kang, Won Ki Park, Se Hoon Kim, Seung Tae Sohn, Tae Sung Lee, Jun Ho An, Ji Yeong Choi, Min Gew Bae, Jae Moon Kim, Kyoung-Mee Han, Heewon Kim, Kyunga Kim, Sung Lim, Do Hoon Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer |
title | Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer |
title_full | Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer |
title_fullStr | Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer |
title_full_unstemmed | Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer |
title_short | Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer |
title_sort | outcomes of radiotherapy for mesenchymal and non-mesenchymal subtypes of gastric cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226608/ https://www.ncbi.nlm.nih.gov/pubmed/32290335 http://dx.doi.org/10.3390/cancers12040943 |
work_keys_str_mv | AT yujeongil outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT parkheechul outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT leejeeyun outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT choichanghoon outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT kangwonki outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT parksehoon outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT kimseungtae outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT sohntaesung outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT leejunho outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT anjiyeong outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT choimingew outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT baejaemoon outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT kimkyoungmee outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT hanheewon outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT kimkyunga outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT kimsung outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer AT limdohoon outcomesofradiotherapyformesenchymalandnonmesenchymalsubtypesofgastriccancer |